At some point, about 50% of the people living with MS will experience clinical depression. This goes beyond simply feeling sad. Left unchecked, MS-related depression can sometimes lead to tragic consequences.
As it relates to multiple sclerosis, mental health must be de-stigmatized, studied more rigorously, and discussed more often.
Returning to the podcast to talk about managing the mood-related symptoms of MS is Dr. Anthony Feinstein, a Professor of Psychiatry at the University of Toronto and an expert in the neuropsychiatry of multiple sclerosis.
We're also talking about study results that show how your beliefs about your disease-modifying therapy can determine whether you stay on it.
Dr. Brian Sandroff joins me to share the outcome of a Kessler Foundation study that may lead to a whole new way for people living with MS who are experiencing substantial disability to improve cognition and mobility impairment through rehabilitation exercise.
You'll hear about a research team that may have identified a biomarker for MS progression. And we'll tell you why that can have a huge impact on treating progressive MS.
We have a lot to talk about! Are you ready for RealTalk MS??!
Perceptions of DMTs can predict MS treatment adherence 2:03
Dr. Brian Sandroff shares the results of Kessler Foundation's robotic exoskeleton-assisted exercise pilot study 7:03
Researchers identify a simple amino sugar as a biomarker for MS progression 17:57
Dr. Anthony Feinstein discusses depression and anxiety in MS 22:30
Share this episode 39:44
Have a minute? Leave a rating & review for the podcast 40:04
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/198
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: jon@realtalkms.com
Phone: (310) 526-2283
And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
National MS Society COVID-19 Vaccine Guidance for People Living with MS
https://www.nationalmssociety.org/coronavirus-covid-19-information/multiple-sclerosis-and-coronavirus/covid-19-vaccine-guidance
STUDY: Beliefs About Medication As Predictors of Medication Adherence In a Prospective Cohort Study Among Persons With Multiple Sclerosis https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-021-02149-0
STUDY: A Pilot Randomized Controlled Trial of Robotic Exoskeleton-Assisted Exercise Rehabilitation in Multiple Sclerosis
https://www.msard-journal.com/article/S22110348(21)00203-0/fulltext
STUDY: Association of a Marker of N-Acetylglucosamine with Progressive Multiple Sclerosis and Neurodegeneration
https://jamanetwork.com/journals/jamaneurology/fullarticle/2779917
Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms
Download the RealTalk MS App for iOS
https://itunes.apple.com/us/app/realtalk-ms/id1436917200
Download the RealTalk MS App for Android
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk
Give RealTalk MS a rating and review
http://www.realtalkms.com/review
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 198
Guests: Dr. Brian Sandroff, Dr. Anthony Feinstein
Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS
